Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruikang Tao

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomed Research International|May 4, 2017
Dissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution ModelYang Peng, Paul Scott, Ruikang Tao, et al.
Cell Death Discovery|December 19, 2023
ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancerChengguo Li, Yuping Yin, Ruikang Tao, et al.
Molecular Medicine Reports|December 20, 2017
Wee1 inhibition can suppress tumor proliferation and sensitize p53 mutant colonic cancer cells to the anticancer effect of irinotecanYunping Yin, Qian Shen, Ruikang Tao, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 5, 2019
Using Transcriptional Signatures to Find Cancer Drivers with LUREDavid Haan, Ruikang Tao, Verena Friedl, et al.
Oncology Reports|October 27, 2018
Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancerXianxiong Ma, Ruikang Tao, Lei Li, et al.
Cancer Research|April 18, 2024
The circMYBL2-Encoded p185 Protein Suppresses Colorectal Cancer Progression by Inhibiting Serine BiosynthesisNing Zhao, Yinghao Cao, Ruikang Tao, et al.
Frontiers in Immunology|December 23, 2024
Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysisRuizhi Zhang, Yisong Gao, Chong Li, et al.
Cancer Science|September 13, 2023
Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancerTao Wang, Weizhen Liu, Qian Shen, et al.
Molecular Cancer Therapeutics|May 31, 2019
The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric CancerYuping Yin, Weizhen Liu, Qian Shen, et al.
American Journal of Cancer Research|April 13, 2017
Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancerYuping Yin, Qian Shen, Peng Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomed Research International|May 4, 2017
Dissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution ModelYang Peng, Paul Scott, Ruikang Tao, et al.
Cell Death Discovery|December 19, 2023
ESRP1-driven alternative splicing of CLSTN1 inhibits the metastasis of gastric cancerChengguo Li, Yuping Yin, Ruikang Tao, et al.
Molecular Medicine Reports|December 20, 2017
Wee1 inhibition can suppress tumor proliferation and sensitize p53 mutant colonic cancer cells to the anticancer effect of irinotecanYunping Yin, Qian Shen, Ruikang Tao, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 5, 2019
Using Transcriptional Signatures to Find Cancer Drivers with LUREDavid Haan, Ruikang Tao, Verena Friedl, et al.
Oncology Reports|October 27, 2018
Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancerXianxiong Ma, Ruikang Tao, Lei Li, et al.
Cancer Research|April 18, 2024
The circMYBL2-Encoded p185 Protein Suppresses Colorectal Cancer Progression by Inhibiting Serine BiosynthesisNing Zhao, Yinghao Cao, Ruikang Tao, et al.
Frontiers in Immunology|December 23, 2024
Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysisRuizhi Zhang, Yisong Gao, Chong Li, et al.
Cancer Science|September 13, 2023
Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancerTao Wang, Weizhen Liu, Qian Shen, et al.
Molecular Cancer Therapeutics|May 31, 2019
The DNA Endonuclease Mus81 Regulates ZEB1 Expression and Serves as a Target of BET4 Inhibitors in Gastric CancerYuping Yin, Weizhen Liu, Qian Shen, et al.
American Journal of Cancer Research|April 13, 2017
Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancerYuping Yin, Qian Shen, Peng Zhang, et al.
Pageof 1